Choreo LLC’s Checkpoint Therapeutics CKPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-98,349
Closed -$397K 1543
2025
Q1
$397K Buy
98,349
+38,072
+63% +$127K 0.01% 948
2024
Q4
$193K Buy
60,277
+1,000
+2% +$3.39K ﹤0.01% 1447
2024
Q3
$130K Sell
59,277
-5,725
-9% -$13.2K ﹤0.01% 1512
2024
Q2
$133K Buy
65,002
+7,080
+12% +$12.6K ﹤0.01% 1379
2024
Q1
$119K Buy
57,922
+38,672
+201% +$77.1K ﹤0.01% 639
2023
Q4
$44.1K Buy
+19,250
New +$41.9K ﹤0.01% 615

Choreo LLC's CKPT Position: Q2 2025 in Review

Choreo LLC sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 98,349 shares — an estimated $397K sold.

Choreo LLC first reported a position in CKPT in Q4 2023 and held it in 6 quarters. The position peaked at $397K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

  • Choreo LLC reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Choreo LLC sold 98,349 Checkpoint Therapeutics shares in Q2 2025, an estimated $397K.
  • Choreo LLC first reported a position in Checkpoint Therapeutics in Q4 2023 and held it in 6 quarters.
  • Choreo LLC's Checkpoint Therapeutics position peaked at $397K in Q1 2025.
  • 0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Choreo LLC's 13F filing for Q2 2025, filed 13 Aug 2025.